NEW YORK, NY / ACCESSWIRE / June 25, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
ProAssurance Corporation (NYSE:PRA)
Class Period: April 26, 2019 - May 7, 2020
Lead Plaintiff Deadline: August 17, 2020
During the class period, ProAssurance Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) ProAssurance lacked adequate underwriting process and risk management controls necessary to set appropriate loss reserves in its Specialty P&C segment; (ii) ProAssurance failed to properly assess a large national healthcare account that experienced losses far exceeding the assumptions made when the account was underwritten; and (iii) as a result, ProAssurance was subject to materially heightened risk of financial loss and reserve charges.
Learn about your recoverable losses in PRA: http://www.kleinstocklaw.com/pslra-1/proassurance-corporation-loss-submission-form?id=7550&from=1
Enphase Energy, Inc. (NASDAQ:ENPH)
Class Period: February 26, 2019 - June 17, 2020
Lead Plaintiff Deadline: August 17, 2020
The complaint alleges that during the class period Enphase Energy, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) its revenues, both U.S. and international, were inflated; (2) the Company engaged in improper deferred revenue accounting practices; (3) the Company's reported base points expansion in gross margins were overstated; and (4) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in ENPH: http://www.kleinstocklaw.com/pslra-1/enphase-energy-inc-loss-submission-form?id=7550&from=1
Chembio Diagnostics, Inc. (NASDAQ:CEMI)
Class Period: March 12, 2020 - June 16, 2020
Lead Plaintiff Deadline: August 17, 2020
According to the filed complaint, defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Chembio's stock price and operated as a fraud or deceit by misrepresenting the efficacy of the Company's Dual Path Platform ("DPP") COVID-19 test. Defendants allegedly achieved this by making false statements about Chembio's DPP COVID-19 test, although they knew or at least recklessly disregarded that there were material performance concerns with the test. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Chembio stock fell precipitously as the prior artificial inflation came out of Chembio's stock price.
Learn about your recoverable losses in CEMI: http://www.kleinstocklaw.com/pslra-1/chembio-diagnostics-inc-loss-submission-form?id=7550&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm
View source version on accesswire.com:
https://www.accesswire.com/595214/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-PRA-ENPH-and-CEMI
